Welcome to Season 5 of the award-winning Precision Medicine Podcast
Clinical conversations about the effective use of precision medicine for cancer care.
Contact us to learn about sponsorship opportunities.
Season 5
EPISODE 62
New Legislation Helps Deliver Appropriate Biomarker Testing to More Cancer Patients When and Where They Need It
Airdate: 09.10.24 | Length: 37:42
Currently, there is a significant divide between the promise of precision medicine and how equitably new innovations are applied to each cancer patient’s treatment journey. Our expert guests, Hilary Gee Goeckner and Kristine Ashcraft, are actively working to close that gap as champions of the American Cancer Society's Cancer Action Network. ASC CAN aims to pass legislation across the US to expand insurance coverage of evidence-based biomarker testing for cancer patients. In this episode of the Precision Medicine Podcast, they explain why it’s so important. Listen here
EPISODE 61
Part 2: How Trevor Maxwell Learned to Man Up to Cancer on His Journey with Colorectal Cancer
Welcome to Part 2 of a two-part colorectal cancer (CRC) awareness series featuring guest Trevor Maxwell, Founder and CEO of Man Up to Cancer, a non-profit that inspires men to connect and avoid isolation during their cancer journeys. Trevor shares what he’s learned since being diagnosed with stage 4 CRC six years ago, the darkness he faced from mental health struggles and how he ultimately decided to “man up” to cancer himself. Listen here
Airdate: 06.04.24 | Length: 33:13
EPISODE 60
Part 1: The Alarming Rise of Colorectal Cancer with Patient Advocate Trevor Maxwell
In this 60th episode of the Precision Medicine Podcast, we learn that 80% of people younger than age 60 are not being effectively screened for colorectal cancer (CRC). Guest Trevor Maxwell, Founder and CEO of Man Up to Cancer, joins us for a two-part series focused on CRC. In Part 1 we discussed the rise of early onset, why basic screening is mission critical and the advancements in treatment options. Listen here
Airdate: 05.02.24 | Length: 37:55
EPISODE 59
From Access to AI – Cancer in America with Dr. Douglas Flora
In this episode of the Precision Medicine Podcast, host Karan Cushman does some time traveling with Dr. Douglas Flora through his lifetime journey with cancer. Dr. Flora is the Medical Director of Oncology Services at St. Elizabeth Healthcare and Editor-in-Chief of AI in Precision Oncology, a peer-reviewed research journal dedicated to advancing artificial intelligence applications in clinical and precision oncology. Listen here
Airdate: 03.25.24 | Length: 36:40
Sponsored by
EPISODE 58
Dr. Pranil Chandra and Dr. Luis Raez: Enabling Comprehensive Genomic Profiling in Lung Cancer
Airdate: 05.10.23 | Length: 51:40
In this episode, hosts Karan Cushman and Clynt Taylor welcome back Dr. Luis Raez, Medical Director and Chief Scientific Officer at Memorial Cancer Institute who is joined by Dr. Pranil Chandra, Chief Genomic Officer of Genomic and Molecular Pathology at PathGroup. Together, we discuss the key barriers to performing comprehensive genomic profiling in lung cancer; how collaboration between oncologists and pathologists can enable a more consistent approach; and the improvements that should be made to close the gaps between the available life-extending, targeted therapies on the market today and the lung cancer patients who need them. Listen here
EPISODE 57
Dr. Debra Patt: Texas Oncology Has an “Easy Button” for Delivering Consistent Precision Oncology Care
To mark the beginning of Season 5, we are honored to welcome Dr. Debra Patt, Executive Vice President of Texas Oncology. As an breast cancer specialist at one of the nation’s largest community cancer practices, Dr. Patt is on the frontlines of oncology care every day. She joins us to discuss how Texas Oncology uses clinical decision-support technologies and health economics and health services research to deliver more consistent precision oncology care to patients at over 200 locations across Texas. Listen here
Airdate: 12.12.22 | Length: 27:40
Season 4
EPISODE 56
Do We Have the Will to Address Inequality in Precision Oncology? A conversation with Dr. Karen Winkfield
In this episode, we are joined by Dr. Karen Winkfield, Executive Director of the Meharry-Vanderbilt Alliance, appointee to President Joe Biden's National Cancer Advisory Board, and co-host of the weekly podcast, 3 Black Docs, which is dedicated to educating the community about health and health disparities in an approachable and entertaining way. Listen here
Airdate: 06.03.22 | Length: 52:40
Airdate: 03.29.22 | Length: 38:19
EPISODE 55
Dr. Stephen Kingsmore on Scaling Whole-Genome Sequencing for Uncovering Genetic Defects in Infants
In episode 55 of the Precision Medicine Podcast, we welcome Dr. Stephen Kingsmore, President and CEO of the Rady Children's Institute for Genomic Medicine. Dr. Kingsmore joins us to discuss the extraordinary role whole-genome sequencing is playing in prolonging and improving the life of critically ill newborns. Listen here
EPISODE 54
Leading Thoracic Oncologist, Dr. Christian Rolfo, Explains How Liquid Biopsies Are Advancing Precision Medicine
Dr. Christian Rolfo, President of the International Society of Liquid Biopsy and Associate Director for Clinical Research at the Center of Thoracic Oncology at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai in New York City, joins us to explain the unique role liquid biopsies are playing in the diagnosis and treatment of cancer. Listen here
Airdate: 02.16.22 | Length: 30:52
Airdate: 01.22.22 | Length: 40:12
EPISODE 53
LUNGevity Leaders Discuss Their Commitment to Educating Lung Cancer Patients About the Importance of Biomarker Testing
In this Precision Medicine Podcast episode, we are joined by Dr. Belinda King-Kallimanis, Director of Patient-Focused Research at LUNGevity—an organization that brings together research, education and support services for patients and caregivers in the lung cancer community—and Nichelle Stigger, LUNGevity board member and lung cancer survivor. They sat down with us to discuss everything from the importance of patient-friendly language in lung cancer to discrepancies in access to biomarker testing and what LUNGevity is doing to improve the status quo. Listen here
Airdate: 11.19.21 | Length: 34:52
EPISODE 52
Then and Now: The Progress of Precision Medicine Diagnostics with Hannah Mamuszka and Lena Chaihorsky of Alva10
In celebration of the three-year anniversary of the Precision Medicine Podcast, we take a look back at how far precision diagnostics have come with the help of one of our first guests Hannah Mamuszka (episode 3), Founder and CEO of Alva10, and her colleague Lena Chaihorsky. Both women are focused on resolving the knowledge gap between payers and diagnostic companies and moving diagnostics to the forefront of the precision medicine conversation. Listen here
How can we resolve the complexities of using precision medicine for cancer care?
Trapelo knows.
